ArticleIndian journal of surgical oncology2026
Extracranial Germ Cell Tumors in Children: A Comprehensive Study on Epidemiology and Treatment Outcomes in 543 Patients.
Article in Indian journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objectives of this study are to investigate the demographic distribution of pediatric extracranial germ cell tumors and to evaluate treatment patterns and outcomes. We analyzed the medical records of 543 consecutive patients aged 0-15 years who were diagnosed with an extracranial germ cell tumor between January 2006 and December 2019. The peak age of presentation was at 1 year for both genders with a second peak at 14 years specifically for girls. An overall female predominance was noted, although there were variations in gender across different age groups. The 5-year overall survival rate for patients receiving complete curative treatment was 83%. Patients with gonadal tumors had a significantly greater probability of overall survival (87.6%) than did those with extragonadal tumors (75.6%) (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.